HUT57587A - Process for producing pharmaceutical compositions having anxiolytic effect - Google Patents

Process for producing pharmaceutical compositions having anxiolytic effect

Info

Publication number
HUT57587A
HUT57587A HU89980A HU98089A HUT57587A HU T57587 A HUT57587 A HU T57587A HU 89980 A HU89980 A HU 89980A HU 98089 A HU98089 A HU 98089A HU T57587 A HUT57587 A HU T57587A
Authority
HU
Hungary
Prior art keywords
pharmaceutical compositions
producing pharmaceutical
anxiolytic effect
anxiolytic
producing
Prior art date
Application number
HU89980A
Other languages
English (en)
Other versions
HU205855B (en
HU890980D0 (en
Inventor
Ken-Ichi Saito
Akihiro Tobe
Heitaro Iwata
Akemichi Baba
Toshio Matsuda
Original Assignee
Mitsubishi Chem Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Chem Ind filed Critical Mitsubishi Chem Ind
Publication of HU890980D0 publication Critical patent/HU890980D0/hu
Publication of HUT57587A publication Critical patent/HUT57587A/hu
Publication of HU205855B publication Critical patent/HU205855B/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/64—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D321/00—Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
    • C07D321/02—Seven-membered rings
    • C07D321/10—Seven-membered rings condensed with carbocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
HU89980A 1988-01-29 1989-01-27 Process for producing anxciety-solving pharmaceutical composition HU205855B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63019055A JP2712222B2 (ja) 1988-01-29 1988-01-29 抗不安薬

Publications (3)

Publication Number Publication Date
HU890980D0 HU890980D0 (en) 1990-03-28
HUT57587A true HUT57587A (en) 1991-12-30
HU205855B HU205855B (en) 1992-07-28

Family

ID=11988746

Family Applications (1)

Application Number Title Priority Date Filing Date
HU89980A HU205855B (en) 1988-01-29 1989-01-27 Process for producing anxciety-solving pharmaceutical composition

Country Status (5)

Country Link
EP (1) EP0355169A4 (hu)
JP (1) JP2712222B2 (hu)
KR (1) KR970009078B1 (hu)
HU (1) HU205855B (hu)
WO (1) WO1989006961A1 (hu)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8803429D0 (sv) * 1988-09-28 1988-09-28 Pharmacia Ab Novel pyridyl- and pyrimidyl derivatives
EP0376633B1 (en) * 1988-12-28 1994-10-12 Suntory Limited Benzoxazepine derivatives
CN101759665B (zh) * 2008-12-23 2012-03-28 江苏恩华药业股份有限公司 取代苯基哌嗪芳烷醇衍生物及其在制备镇痛药物中的应用
CN102850318A (zh) * 2011-07-01 2013-01-02 中国人民解放军军事医学科学院毒物药物研究所 新的选择性5-羟色胺重摄取抑制剂及其医药用途
JP7431800B2 (ja) * 2018-08-10 2024-02-15 フィルメニッヒ インコーポレイテッド Ｔ２ｒ５４の拮抗薬ならびにその組成物および使用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670200A1 (de) * 1967-03-22 1972-03-02 Byk Gulden Lomberg Chem Fab Neue arylsubstituierte Piperazinylcarbonsaeureanilide und Verfahren zu deren Herstellung
BE758380A (fr) * 1969-11-04 1971-04-16 Sumitomo Chemical Co Procede de preparation de derives d'aryl-cetones
GB1574019A (en) * 1977-01-14 1980-09-03 Joullie International Sa Therapeutically useful 3,4,5-trimethoxybenzene derivatives
JPS565462A (en) * 1979-06-26 1981-01-20 Mitsubishi Chem Ind Ltd Piperazinylalkoxyindanes and their acid addition salt
JPS56122351A (en) * 1980-02-29 1981-09-25 Otsuka Pharmaceut Co Ltd Oxyindole derivative
JPS58192824A (ja) * 1982-05-07 1983-11-10 Mitsubishi Chem Ind Ltd 血圧降下剤
JPS597120A (ja) * 1982-07-02 1984-01-14 Mitsubishi Chem Ind Ltd 血圧降下剤
JPS5910517A (ja) * 1982-07-09 1984-01-20 Mitsubishi Chem Ind Ltd 血圧降下剤
JPS5929665A (ja) * 1982-08-11 1984-02-16 Sumitomo Chem Co Ltd ピペラジン誘導体及びその酸付加塩
GB8303946D0 (en) * 1983-02-12 1983-03-16 Recordati Chem Pharm Antihypertensive n-piperazinylalkanoylanilides
US4701456A (en) * 1984-09-19 1987-10-20 Warner-Lambert Company Aminoalkoxybenzopyranones as antipsychotic and anxiolytic agents
ZA856559B (en) * 1984-09-19 1986-04-30 Warner Lambert Co Aminoalkoxybenzopyranones as antipsychotic and anxiolytic agents

Also Published As

Publication number Publication date
EP0355169A1 (en) 1990-02-28
JP2712222B2 (ja) 1998-02-10
HU205855B (en) 1992-07-28
EP0355169A4 (en) 1991-05-22
JPH01193221A (ja) 1989-08-03
HU890980D0 (en) 1990-03-28
KR900700104A (ko) 1990-08-11
WO1989006961A1 (en) 1989-08-10
KR970009078B1 (ko) 1997-06-05

Similar Documents

Publication Publication Date Title
HUT49290A (en) Process for producing retarde pharmaceutical compositions
HUT50851A (en) Process for producing intervenous pharmaceutical compositions
HU896444D0 (en) Process for the preparation of pharmaceutical compositions
HUT58326A (en) Process for producing pipeidine derivatives and pharmaceutical compositions containing them
HUT49316A (en) Process for producing didehydro-d3-vitamine derivatives and pharmaceutical compositions containing them
HUT48900A (en) Process for producing phosphoruus-containing squalene-synthetase inhibitores and pharmaceutical compositions containing them
HUT53644A (en) Process for producing pharmaceutical nukleozides and pharmaceutical compositions containing them
HUT54046A (en) Process for producing pharmaceutical compositions
HUT48887A (en) Process for producing cyclopentenyl-purin derivatives and pharmaceutical compositions containing them
HUT54139A (en) Process for producing n-heteroaryl-4-quinolineamine derivatives and pharmaceutical compositions comprising such compounds
HUT54041A (en) Process for producing stable pharmaceutical compositions
HUT56098A (en) Process for producing azanaphtalenesultame derivatives and pharmaceutical compositions containing them
HUT52944A (en) Process for producing granulated pharmaceutical compositions
HUT59908A (en) Process for producing benzazepine- and benzo-thiazepine derivatives and pharmaceutical compositions containing them
HUT49317A (en) Process for producing 16-dehydro-d3-vitamine derivatives and pharmaceutical compositions containing them
HUT48870A (en) Process for producing aminoalkoxyphenyl derivatives and pharmaceutical compositions comprising same
HUT50473A (en) Process for producing imidazopyridazinones and pharmaceutical compositions comprising such compounds
HUT56078A (en) Process for producing piridazine derivatives and pharmaceutical compositions containing them
HUT56342A (en) Process for producing capsoicin derivatives and pharmaceutical compositions comprising such compounds
HUT53625A (en) Process for producing 2-iminobenzothiazole derivatives and pharmaceutical compositions comprising same
HUT49871A (en) Process for producing indolylpiperidine derivatives and pharmaceutical compositions comprising same
HUT47119A (en) Process for producing 3-propenyl-cefem derivatives and pharmaceutical compositions comprising such compounds
HUT50829A (en) Process for producing thienoazepines and pharmaceutical compositions comprising same
HUT46644A (en) Process for producing propylophenone derivatives and pharmaceutical compositions comprising the same
HUT56373A (en) Process for producing pyranobenzoxadiazole derivatives and pharmaceutical compositions comprising such compounds

Legal Events

Date Code Title Description
HMM4 Cancellation of final prot. due to non-payment of fee